Tetanus Control Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Tetanus Control. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Tetanus Control Indian Medical PG Question 1: A young male came to the hospital with a clean-cut wound without any bleeding. The patient received a full course of tetanus vaccination 10 years ago. What is the best management for this patient?
- A. Single-dose tetanus toxoid (Correct Answer)
- B. Human tetanus immunoglobulin only
- C. Human tetanus immunoglobulin and a full course of vaccine
- D. No treatment required
Tetanus Control Explanation: ***Single-dose tetanus toxoid***
- For a **clean-cut wound** in a patient who completed a **primary tetanus vaccination series** and received their last dose more than 5 years ago but less than 10 years ago, a **single booster dose** of tetanus toxoid is recommended. [1]
- A booster ensures continued protection, as vaccine-induced immunity wanes over time, but the prior full course provides a robust anamnestic response with a single dose.
*Human tetanus immunoglobulin and a full course of vaccine*
- This regimen (tetanus immunoglobulin + vaccine) is typically reserved for patients with **unvaccinated status**, an **unknown vaccination history**, or a **severely contaminated wound** (e.g., rusty nail, soil contamination) who have not been fully vaccinated.
- The patient had a **clean-cut wound** and completed a full course of vaccination 10 years ago, making immunoglobulin unnecessary and a full course of vaccine excessive.
*Human tetanus immunoglobulin only*
- Administering **tetanus immunoglobulin alone** is appropriate for immediate, passive immunity in situations where a patient is unvaccinated or has an unknown vaccination status and has a significant risk of tetanus from a contaminated wound. [2]
- This patient has a clean wound and a history of full vaccination, so a booster is sufficient to stimulate active immunity.
*No treatment required*
- While the patient was fully vaccinated 10 years ago, the protection from tetanus vaccination can **wane over time**, especially after 5-10 years.
- A **booster dose** is crucial to maintain adequate protection against tetanus, even for a clean wound, given the 10-year interval since the last dose.
Tetanus Control Indian Medical PG Question 2: Most common symptom of tetanus is
- A. Tonic-clonic seizures
- B. Lock-jaw (Correct Answer)
- C. Opisthotonus
- D. Hemiplegia
Tetanus Control Explanation: ***Lock-jaw***
- **Trismus**, or "lock-jaw," is the **hallmark initial symptom** of tetanus, resulting from spasms of the masseter muscles [1].
- It often progresses to generalized muscle rigidity and spasms, making it difficult to open the mouth or swallow [1].
*Tonic-clonic seizures*
- While tetanus can cause severe muscle spasms, **generalized tonic-clonic seizures** are not the most common initial or presenting symptom [2].
- Tetanic spasms are characterized by sustained muscle contractions, which are distinct from the rhythmic jerking seen in tonic-clonic seizures.
*Hemiplegia*
- **Hemiplegia**, or unilateral paralysis, is typically associated with **stroke** or focal brain injury [2].
- Tetanus causes **generalized muscular rigidity** and spasms, not focal paralysis.
*Opisthotonus*
- **Opisthotonus** is a severe symptom of tetanus characterized by **extreme hyperextension of the head and spine**, forming an arch.
- While a classic sign of severe tetanus, it is usually a **later manifestation** after lock-jaw has developed.
Tetanus Control Indian Medical PG Question 3: In a 10-year-old school child under the school health program, which vaccine should be administered?
- A. DPT
- B. BCG
- C. Td (Correct Answer)
- D. MMR
Tetanus Control Explanation: ***Td (Tetanus-Diphtheria)***
- For a 10-year-old child under the school health program in India, the recommended vaccination is a booster dose of **Td (tetanus-diphtheria)**.
- This ensures continued **protection against tetanus and diphtheria**, as immunity from the primary series may wane over time.
- **Td is preferred over TT** (tetanus toxoid alone) as it provides protection against both tetanus and diphtheria.
- This is administered at **10 years and 16 years** as per the Indian Academy of Pediatrics immunization schedule.
*DPT*
- **DPT (diphtheria, pertussis, tetanus)** is administered in infancy and early childhood (at 6, 10, and 14 weeks, with boosters at 16-24 months and 4-6 years).
- The **pertussis component is not given** in later childhood or adolescence due to increased reactogenicity in older children.
*BCG*
- **BCG (Bacille Calmette-Guérin)** vaccine protects against tuberculosis and is given **at birth** in endemic areas like India.
- It is **not routinely administered** to a 10-year-old unless there are specific risk factors or documented non-vaccination status.
*MMR*
- **MMR (measles, mumps, rubella)** vaccine is given as **two doses**: first at 9-12 months and second at 16-24 months (or 4-6 years).
- A 10-year-old child would have **already completed** their MMR vaccination schedule.
Tetanus Control Indian Medical PG Question 4: Which of the following is least appropriate for the treatment of tetanus?
- A. Clindamycin
- B. Penicillin
- C. Doxycycline (Correct Answer)
- D. Metronidazole
Tetanus Control Explanation: ***Doxycycline***
- While doxycycline is an antibiotic, it is **not considered a primary agent** for treating tetanus due to its generally inferior efficacy against *Clostridium tetani* compared to other options.
- The main goal of antibiotic therapy in tetanus is to **eradicate vegetative forms of C. tetani** at the wound site, to stop further toxin production, which doxycycline is not optimally suited for.
*Clindamycin*
- **Clindamycin** is an effective antibiotic against *Clostridium tetani* and is often used in combination with metronidazole.
- Its mechanism of action involves **inhibiting bacterial protein synthesis**, thereby preventing bacterial growth and toxin production.
*Penicillin*
- **Penicillin** was historically a first-line antibiotic for tetanus due to its bactericidal activity against *C. tetani*.
- However, some concerns exist about its potential to **exacerbate seizures** due to its GABA antagonism, leading to a preference for metronidazole.
*Metronidazole*
- **Metronidazole** is the antibiotic of choice for tetanus as it is highly effective against anaerobic bacteria like *C. tetani*.
- It is preferred over penicillin due to its similar efficacy and **lack of CNS excitability effects**.
Tetanus Control Indian Medical PG Question 5: Silicosis can be controlled by:
- A. BCG vaccination
- B. Rigorous dust control (Correct Answer)
- C. Adequate personal hygiene
- D. Effective implementation of factories act
Tetanus Control Explanation: ***Rigorous dust control***
- **Silicosis** is a lung disease caused by inhaling **crystalline silica dust**, making dust control the primary preventive measure
- This includes **engineering controls** such as ventilation, wet methods, local exhaust systems, and enclosure to minimize airborne dust levels
- **Primary prevention** through environmental control is the most effective strategy
*BCG vaccination*
- **BCG vaccination** is used to prevent **tuberculosis**, not silicosis
- While patients with silicosis have increased risk for tuberculosis, BCG does not directly prevent or control silicosis development
*Adequate personal hygiene*
- Good **personal hygiene** is important for overall health but does not prevent inhalation of **silica dust** in occupational settings
- Does not address the fundamental environmental exposure that causes silicosis
*Effective implementation of factories act*
- The **Factories Act** provides legal frameworks for worker safety and encompasses broad measures
- However, the specific control of silicosis depends directly on technical measures of **rigorous dust control**, which are implemented through but not synonymous with such legislation
Tetanus Control Indian Medical PG Question 6: Due to a measles outbreak in a community, a medical officer decided to immunize a child aged seven months with measles vaccine. When should the next measles vaccine be administered?
- A. Not required
- B. When the child completes nine months of age (Correct Answer)
- C. When the child completes fifteen months of age
- D. After four weeks
Tetanus Control Explanation: ***When the child completes nine months of age***
- A measles vaccine given at **seven months during an outbreak** is considered a **zero-dose** or **early dose** and does NOT replace the routine immunization schedule.
- According to the **Indian National Immunization Schedule**, the routine first dose of measles vaccine (MR vaccine) is given at **9 months of age**, regardless of whether an earlier outbreak dose was administered.
- Vaccines given before 9 months have **reduced efficacy** due to interference from maternal antibodies, making the 9-month dose essential for adequate seroconversion.
- After the 9-month dose, a second dose is given at **16-24 months** as per routine schedule.
*When the child completes fifteen months of age*
- While 15-18 months is appropriate timing for the **second dose** of measles vaccine in the routine schedule, it is not the immediate next dose after a 7-month outbreak vaccination.
- The child still requires the **routine 9-month dose first**, followed by the second dose at 16-24 months.
- Skipping the 9-month dose and going directly to 15 months would leave a prolonged gap without adequate protection.
*Not required*
- This is **incorrect** because early doses given before 9 months are considered zero-doses and do not provide reliable long-term immunity.
- The routine schedule **must still be followed** to ensure proper immunization, starting with the 9-month dose.
*After four weeks*
- A four-week interval after the 7-month dose is **too short** and not recommended in immunization guidelines.
- There is **no indication** for such an early repeat dose; the child should wait until the routine 9-month schedule for the next dose.
Tetanus Control Indian Medical PG Question 7: Match the following:
Column A:
a. Syphilis
b. Chickenpox
c. COVID-19
d. Hepatitis A
Column B:
1. 6 Days
2. 90 Days
3. 16 Days
4. 28 Days
- A. a-2, b-3, c-1, d-4 (Correct Answer)
- B. a-3, b-4, c-2, d-1
- C. a-1, b-4, c-2, d-3
- D. a-3, b-4, c-1, d-2
Tetanus Control Explanation: ***a-2, b-3, c-1, d-4***
- **Syphilis**: 90 days represents the **maximum incubation period** for *Treponema pallidum* (range 10-90 days, typical 21 days). While not the most common presentation time, it remains medically accurate and is the only viable match among available options.
- **Chickenpox**: 16 days falls within the typical incubation period for **varicella-zoster virus** (range 10-21 days, commonly 14-16 days).
- **COVID-19**: 6 days is consistent with the **median incubation period** for SARS-CoV-2 (range 2-14 days, mean 5-6 days).
- **Hepatitis A**: 28 days represents the **typical incubation period** for HAV (range 15-50 days, average 28-30 days).
*a-3, b-4, c-2, d-1*
- Incorrectly assigns **Syphilis** 16 days (below the 10-90 day range's typical value), **COVID-19** 90 days (far exceeding the 2-14 day range), and **Hepatitis A** only 6 days (well below the minimum 15-day period).
*a-1, b-4, c-2, d-3*
- Incorrectly matches **Syphilis** with 6 days (insufficient for *T. pallidum* to produce primary chancre), **Chickenpox** with 28 days (exceeds the typical VZV range), and **Hepatitis A** with 16 days (below typical range).
*a-3, b-4, c-1, d-2*
- Incorrectly assigns **Syphilis** 16 days, **Chickenpox** 28 days (exceeding typical range), and **Hepatitis A** 90 days (inconsistent with acute HAV infection pattern).
Tetanus Control Indian Medical PG Question 8: Which of the following statements about leptospirosis is true?
- A. Rats are prime reservoirs (Correct Answer)
- B. Fluoroquinolones are the drug of choice
- C. Person to person Transmission is common
- D. Hepatorenal syndrome may occur in severe cases
Tetanus Control Explanation: ***Rats are prime reservoirs***
- **Rats** and other wild and domestic animals (e.g., cattle, pigs, dogs, rodents) are the primary **reservoir hosts** for *Leptospira* bacteria, shedding the bacteria in their urine.
- Humans become infected through contact with contaminated water or soil, or infected animal tissues/urine.
*Fluoroquinolones are the drug of choice*
- **Fluoroquinolones** are generally not the drug of choice for leptospirosis.
- First-line treatment typically involves **doxycycline** for mild cases and **intravenous penicillin G** or **ceftriaxone** for severe disease.
*Person to person Transmission is common*
- **Person-to-person transmission** of leptospirosis is extremely rare and not considered a common route of infection.
- The disease is usually acquired through environmental exposure to contaminated animal urine.
*Hepatorenal syndrome may occur in severe cases.*
- While **hepatic** (liver) and **renal** (kidney) dysfunction are characteristic of severe leptospirosis (Weil's disease), the term **hepatorenal syndrome** is a specific diagnosis describing acute kidney injury in patients with advanced liver cirrhosis.
- The kidney and liver damage in leptospirosis are direct effects of the bacterial infection, rather than a secondary complication of liver cirrhosis.
Tetanus Control Indian Medical PG Question 9: BCG vaccine should be administered:
- A. Immediately after birth (Correct Answer)
- B. At the age of 1 month
- C. At the age of 6 months
- D. At the age of 1 year
Tetanus Control Explanation: **Explanation:**
**1. Why Option A is Correct:**
According to the National Immunization Schedule (NIS) in India and WHO guidelines, the **BCG (Bacillus Calmette-Guérin)** vaccine should be administered **at birth** or as soon as possible thereafter. The primary medical rationale is to provide early protection against severe, disseminated forms of childhood tuberculosis, specifically **Tubercular Meningitis** and **Miliary Tuberculosis**. Since newborns in endemic areas are at immediate risk of exposure, early vaccination ensures the induction of cell-mediated immunity before natural infection occurs.
**2. Why Other Options are Incorrect:**
* **Options B, C, and D:** While BCG can be given up to the age of one year if missed at birth, these are not the *recommended* times for administration. Delaying the vaccine increases the window of vulnerability for the infant. Furthermore, if the vaccine is delayed beyond birth, the dose changes (0.05 ml at birth vs. 0.1 ml after 4 weeks), and if delayed beyond one year, it is generally not recommended under the NIS as the protective efficacy diminishes.
**3. High-Yield Clinical Pearls for NEET-PG:**
* **Dose:** 0.05 ml (until 1 month of age); 0.1 ml (beyond 1 month up to 1 year).
* **Route:** Strictly **Intradermal** (left upper arm) using an Omega/Tuberculin syringe.
* **Strain:** Danis 1331 is the most commonly used strain in India.
* **Diluent:** Normal Saline (NS). Never use Distilled Water (causes irritation/sterile abscess).
* **The Phenomenon:** A papule forms, followed by a crust and a permanent **pitted scar** (the only vaccine to leave a characteristic scar).
* **Direct BCG:** In India, BCG is given "directly" without a prior Mantoux test up to 1 year of age.
Tetanus Control Indian Medical PG Question 10: What is the duration of immunity provided by the yellow fever vaccine, and when does it begin?
- A. 6 years starting from 6 days after vaccination
- B. 6 years starting from 10 days after vaccination
- C. 10 years starting from 6 days after vaccination
- D. 10 years starting from 10 days after vaccination (Correct Answer)
Tetanus Control Explanation: **Explanation:**
The **Yellow Fever vaccine (17D strain)** is a live-attenuated vaccine that provides robust immunity. According to the **International Health Regulations (IHR)**, the validity of the vaccination certificate for international travel traditionally begins **10 days** after the date of vaccination. This 10-day window is the time required for the body to develop protective neutralizing antibodies.
**Why Option D is Correct:**
Historically, the immunity was documented to last for **10 years**, and the certificate required a booster every decade. While the WHO updated its position in 2016 stating that a single dose provides life-long protection, for the purpose of **NEET-PG and International Health Regulations (IHR)**, the legal validity of the certificate remains defined as starting from **10 days** post-vaccination and lasting for **10 years** (though many countries now accept it as valid for life).
**Analysis of Incorrect Options:**
* **Options A & B:** The duration of 6 years is incorrect. This figure is often confused with the validity period of the Cholera vaccine certificate (which is 6 months, not years).
* **Option C:** While the duration is 10 years, the immunity is not legally recognized until the 10th day. The 6-day period is irrelevant to Yellow Fever protocols.
**High-Yield Clinical Pearls for NEET-PG:**
* **Strain:** 17D strain (grown in chick embryo).
* **Route/Dose:** 0.5 ml, Subcutaneous.
* **Contraindications:** Infants <6 months, egg allergy, thymic disease, and symptomatic HIV/immunocompromised states.
* **Cold Chain:** It is highly heat-sensitive; must be stored between **+2°C to +8°C** (or frozen at -50°C to -15°C at central levels).
* **Rule of 10:** Remember **10 days to 10 years** for easy recall of certificate validity.
More Tetanus Control Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
